These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6969450)

  • 21. Aerobic resistance of Trichomonas vaginalis to metronidazole induced in vitro.
    Tachezy J; Kulda J; Tomková E
    Parasitology; 1993 Jan; 106 ( Pt 1)():31-7. PubMed ID: 8479798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalis.
    Blaha C; Duchêne M; Aspöck H; Walochnik J
    J Antimicrob Chemother; 2006 Feb; 57(2):273-8. PubMed ID: 16344287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic relatedness of Trichomonas vaginalis reference and clinical isolates.
    Cornelius DC; Mena L; Lushbaugh WB; Meade JC
    Am J Trop Med Hyg; 2010 Dec; 83(6):1283-6. PubMed ID: 21118935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis.
    Adagu IS; Nolder D; Warhurst DC; Rossignol JF
    J Antimicrob Chemother; 2002 Jan; 49(1):103-11. PubMed ID: 11751773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a time-kill technique for susceptibility testing of Trichomonas vaginalis.
    Krieger JN; Dickins CS; Rein MF
    Antimicrob Agents Chemother; 1985 Mar; 27(3):332-6. PubMed ID: 3873214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism and metronidazole uptake in Trichomonas vaginalis isolates with different metronidazole susceptibilities.
    Müller M; Gorrell TE
    Antimicrob Agents Chemother; 1983 Nov; 24(5):667-73. PubMed ID: 6607028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the in vitro activity of ceragenins against Trichomonas vaginalis.
    Polat ZA; Cetin A; Savage PB
    Acta Parasitol; 2016 Mar; 61(2):376-81. PubMed ID: 27078662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis.
    Lossick JG; Müller M; Gorrell TE
    J Infect Dis; 1986 May; 153(5):948-55. PubMed ID: 3486237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Trichomonas vaginalis activity of 1,10-phenanthroline-5,6-dione-based metallodrugs and synergistic effect with metronidazole.
    Vargas Rigo G; Petro-Silveira B; Devereux M; McCann M; Souza Dos Santos AL; Tasca T
    Parasitology; 2019 Aug; 146(9):1179-1183. PubMed ID: 30207253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activities of metronidazole and niridazole against Trichomonas vaginalis clinical isolates.
    Yarlett N; Hof H; Yarlett NC
    J Antimicrob Chemother; 1987 Jun; 19(6):767-70. PubMed ID: 3497149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metronidazole-resistant strains of Trichomonas vaginalis display increased susceptibility to oxygen.
    Rasoloson D; Tomková E; Cammack R; Kulda J; Tachezy J
    Parasitology; 2001 Jul; 123(Pt 1):45-56. PubMed ID: 11467782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycoplasma hominis impacts gene expression in Trichomonas vaginalis.
    Fürnkranz U; Henrich B; Walochnik J
    Parasitol Res; 2018 Mar; 117(3):841-847. PubMed ID: 29368037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites.
    Inceboz T; Inceboz U; Ozturk S
    J Chemother; 2004 Oct; 16(5):459-62. PubMed ID: 15565912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative in vitro sensitivity to metronidazole of Trichomonas vaginalis with isolates and clones.
    Sithithaworn P; Sithithaworn J; Kitjaroen K; Pairojkul C; Ratananurakpong S; Sriswangwonk T
    Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):279-84. PubMed ID: 2609217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'In vitro' study of chemotherapeutic activity of sulphimidazole on some sensitive and metronidazole-resistant Trichomonas vaginalis strains.
    Malagoli M; Rossi T; Baggio A; Zandomeneghi G; Zanca A; Casolari C; Castelli M
    Pharmacol Res; 2002 Nov; 46(5):469-72. PubMed ID: 12419652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Metronidazole resistance test in vitro in strains of Trichomonas vaginalis isolated from clinical material. 1. Test conditions].
    Tachezy J; Kulda J
    Cesk Epidemiol Mikrobiol Imunol; 1991 Mar; 40(2):89-96. PubMed ID: 1827366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis.
    Küng E; Pietrzak J; Klaus C; Walochnik J
    Int J Antimicrob Agents; 2016 Mar; 47(3):232-4. PubMed ID: 26899578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis.
    Crowell AL; Sanders-Lewis KA; Secor WE
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1407-9. PubMed ID: 12654679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vitro Susceptibility of Iranian Isolates of Trichomonas vaginalis to Metronidazole.
    Matini M; Maghsood AH; Mohebali M; Rabiee S; Fallah M; Rezaie S; Rezaeian M
    Iran J Parasitol; 2016; 11(1):46-51. PubMed ID: 27095968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of disulfiram (bis(diethylthiocarbamoyl)disulphide) and ditiocarb (diethyldithiocarbamate) against metronidazole-sensitive and -resistant Trichomonas vaginalis and Tritrichomonas foetus.
    Bouma MJ; Snowdon D; Fairlamb AH; Ackers JP
    J Antimicrob Chemother; 1998 Dec; 42(6):817-20. PubMed ID: 10052908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.